BGI Genomics and digital health start-up, Pryzm Health (Pryzm), have signed a Memorandum of Understanding (MoU)  for collaboration to advance precision public health in Australia. 

With their complementary expertise and technology, BGI Genomics and Pryzm will develop foundational capabilities to drive equitable access to precision medicine approaches across the health system. This movement, termed precision public health, will enable more rapid diagnoses, improved efficiency, better patient outcomes and more economically-sustainable health practices.

Pryzm is an innovative digital health start-up focused on guiding personal and clinical health decisions by accelerating diagnosis of rare and inherited diseases. The collaboration with BGI Genomics aims to improve the utility of cost-effective genomic testing for the clinic and lower the barriers for access to precision healthcare in Australia by harnessing the synergy between the complementary technologies of BGI Genomics in genomics and Pryzm in the integration and analytics of genomic information and electronic health data.